MUC5B Is the predominant mucin glycoprotein in chronic otitis media fluid

Diego Preciado1, Samita Goyal, Michael Rahimi

  • 1Department of Pediatric Otolaryngology-Head and Neck Surgery, Center for Genetic Medicine Research, Children's National Medical Center, 111 Michigan Avenue Northwest, Washington, DC 20001, USA. dpreciad@cnmc.org

Pediatric Research
|June 10, 2010
PubMed

Insights

Researchers identified the predominant mucin in middle ear fluid from children with chronic otitis media (COM). Mucin MUC5B was found to be significantly more abundant than MUC5AC in COM effusions.

Area of Science:

  • Otolaryngology
  • Proteomics
  • Molecular Biology

Background:

  • Chronic otitis media (COM) involves middle ear fluid and conductive hearing loss.
  • Mucous glycoproteins (mucins) increase middle ear effusion viscosity.
  • The molecular identity of secreted mucins in middle ear fluid remains uncharacterized.

Purpose of the Study:

  • To identify and quantify the specific mucin proteins present in middle ear effusions from children with COM.
  • To determine the predominant mucin in middle ear secretions associated with COM.

Main Methods:

  • Middle ear effusions were collected from children undergoing myringotomy for COM.
  • Proteomic analysis using liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed.
  • Western blot analyses with mucin-specific antibodies validated the mass spectrometry findings.

Main Results:

  • Mucin MUC5B was identified in all six tested middle ear effusion samples.
  • Mucin MUC5AC was identified in only one of the six samples.
  • Western blot analysis showed a 6.4-fold higher signal for MUC5B compared to MUC5AC.

Conclusions:

  • Both MUC5AC and MUC5B mucins are present in middle ear effusions of COM.
  • MUC5B is the predominant mucin in middle ear secretions associated with chronic otitis media.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...